"Sansum Diabetes Research Institute is dedicated to improving the lives of people impacted by diabetes through research, education, and clinical care."

During the past decade, Sansum Diabetes Research Institute conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 18 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 8 clinical trials were completed. i.e. 29.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sansum Diabetes Research Institute" #1 sponsor was "Sansum Diabetes Research Institute" with 31 trials, followed by "Abbott Diabetes Care" with 11 trials sponsored, "Medtronic Diabetes" with 7 trials sponsored, "University of Virginia" with 6 trials sponsored and "DexCom, Inc." with 6 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sansum Diabetes Research Institute" #1 collaborator was "Harvard University" with 10 trials as a collaborator, "Jaeb Center for Health Research" with 7 trials as a collaborator, "University of California, Santa Barbara" with 7 trials as a collaborator, "Mayo Clinic" with 6 trials as a collaborator and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 6 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Sansum Diabetes Research Institute" are "Type 1 Diabetes Mellitus" (22 trials), "Type 1 Diabetes" (16 trials), "Diabetes Mellitus, Type 1" (13 trials), "Diabetes Mellitus" (11 trials) and "Diabetes Mellitus, Type 2" (9 trials). Many other conditions were trialed in "Sansum Diabetes Research Institute" in a lesser frequency.

Most popular intervention types in "Sansum Diabetes Research Institute" are "Device" (57 trials), "Drug" (19 trials), "Other" (6 trials), "Behavioral" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "FreeStyle Libre Flash Glucose Monitoring System" (6 trials), "Closed-Loop Control System" (3 trials), "Placebo" (3 trials), "Abemaciclib" (2 trials) and "Artificial Pancreas" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sansum Diabetes Research Institute" are 77 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Sansum Diabetes Research Institute". 1 are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 70 completed trials in Sansum Diabetes Research Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sansum Diabetes Research Institute, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 39 trials that are defined as “Not Applicable".